Clinical Trials Directory

Trials / Completed

CompletedNCT02524600

Technical Performance of a New Cardiac Technology "IQ-SPECT" Applied to SCINTI-CT Myocardial Imaging With 99mTc-Sestamibi in Coronary Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cardiological examination is one of the major directions in nuclear medicine for detection of myocardial ischemia in patients with suspected coronary artery disease. In Caen, they constitute 20% of the activity of nuclear medicine. It is evaluating a new versatile innovative technology (IQ-SPECT) for performing rapid nuclear cardiological examinations (4 minutes) and quality on a SCINTI-CT camera for correcting the mitigation. This technical solution IQ-SPECT was made available to the nuclear medicine department in August 2011. To date, apart from the work on heart ghosts and one publication in abstract form in 2009, no other study have been published. The goal of the study is to study the technical performance of the innovative technology IQ-SPECT during a SCINTI-CT imaging in patients suspected of coronary disease .

Conditions

Interventions

TypeNameDescription
DEVICEmyocardial IQ-SPECT imaging applied to scintigraphic imaging
DEVICEscintigraphic imaging

Timeline

Start date
2012-01-01
Primary completion
2012-06-01
First posted
2015-08-17
Last updated
2015-08-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02524600. Inclusion in this directory is not an endorsement.